THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;APOTEX TECHNOLOGIES INC.
发明人:
SPINO, MICHAEL,DUNAIEF, JOSHUA LAWRENCE
申请号：
MYPI 2011003478
公开号：
MY161269A
申请日:
2009.11.12
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
THERE IS PROVIDED USE OF ORALLY AVAILABLE OR TOPICALLY APPLIED DEFERIPRONE FOR PREVENTION OF IRON-INDUCED EYE DAMAGE. THE USE MAY BE FOR PREPARATION OF A MEDICAMENT OR IN A METHOD OF PREVENTING IRON-INDUCED EYE DAMAGE TO AN EYE OF A SUBJECT AT RISK FOR IRON-INDUCED EYE DAMAGE, THE METHOD COMPRISING ADMINISTERING A PROPHYLACTICALLY EFFECTIVE AMOUNT OF DEFERIPRONE TO THE SUBJECT. THERE IS ALSO PROVIDED THE USE OF DEFERIPRONE FOR TREATMENT OF IRON-RELATED EYE DISORDERS. THE USE MAY BE FOR PREPARATION OF A MEDICAMENT OR IN A METHOD OF TREATMENT OF DAMAGE TO AN EYE OF A HAVING EYE DAMAGE ASSOCIATED WITH IRON, THE METHOD COMPRISING TOPICALLY ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF DEFER PRONE TO THE SUBJECT.
